MétaCan
Menu
Back to cohort
Record W4387209030 · doi:10.1093/ecco-jcc/jjad166

Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients

2023· article· en· W4387209030 on OpenAlexaff
Benjamin Y H Bai, Mark Reppell, Nizar Smaoui, Jeffrey F. Waring, Valerie Pivorunas, Heath Guay, Simeng Lin, Neil Chanchlani, Claire Bewshea, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad, Carl A. Anderson, Vinod Patel, Zia Mazhar, Rebecca Saich, Ben Colleypriest, Tariq Iqbal, Vishal Kaushik, Senthil Murugesan, Salil Singhi, Sean Weaver, Cathryn Preston, Melissa Smith, Dharamveer Basude, Amanda Beale, Sarah Langlands, Natalie Direkze, Miles Parkes, Franco Torrente, Juan De La Revella Negro, Chris Ewen MacDonald, Stephen M. Evans, Anton Gunasekera, Alka Thakur, David Elphick, Achuth Shenoy, Chuka Nwokolo, Anjan Dhar, A.T. Cole, Anurag K. Agrawal, Stephen Bridger, Julie Doherty, Sheldon C. Cooper, Shanika de Silva, Craig Mowat, Phillip Mayhead, Charlie W. Lees, Gareth Jones, J. W. Hart, Daniel R. Gaya, Richard K. Russell, Lisa Gervais, Paul Dunckley, Tariq Mahmood, Paul Banim, Sunil Sonwalkar, Deb Ghosh, Rosemary Phillips, Amer Azaz, Shaji Sebastian, Richard Shenderey, Lawrence Armstrong, Claire Bell, Radhakrishnan Hariraj, Helen Matthews, Hasnain Jafferbhoy, Christian P. Selinger, Veena Zamvar, John de Caestecker, Anne Willmott, Richard Miller, Palani Sathish Babu, Christos Tzivinikos, Stuart Bloom, Guy Chung‐Faye, Nicholas M. Croft, John Fell, Marcus Harbord, Ailsa Hart, Ben Hope, Peter M. Irving, James O. Lindsay, Joel Mawdsley, Alistair McNair, Kevin Monahan, Charles Murray, Timothy R. Orchard, Thankam Paul, Richard Pollok, Neil Shah, Sonia Bouri, Matt Johnson, Anita Modi, Kasamu Dawa Kabiru, Bijay Baburajan, Bim Bhaduri, Andrew Fagbemi, Scott Levison, Jimmy K. Limdi, Gill Watts, Stephen Foley, Arvind Ramadas, George MacFaul, John Mansfield, Leonie Grellier, Mary‐Anne Morris, Mark Tremelling, C J Hawkey, Sian Kirkham, Charles P J Charlton, Astor Rodrigues, Alison Simmons, Stephen J. Lewis, Jonathon Snook, Mark Tighe, Patrick Goggin, Aminda N De Silva, Simon Lal, Mark Smith, Simon Panter, Fraser Cummings, Suranga Dharmisari, Martyn Carter, David Watts, Zahid Mahmood, Bruce McLain, Sandip Sen, Anna J Pigott, David Hobday, Emma Wesley, Richard L. Johnston, Cathryn Edwards, John Beckly, Deven Vani, S. Ramakrishnan, Nigel Trudgill, Rachel Cooney, Andy Bell, Neeraj Prasad, J Gordon, Matthew Brookes, Andrew A. Li

Bibliographic record

VenueJournal of Crohn s and Colitis · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity Hospital Foundation
FundersCrohn's and Colitis UKNational Institute for Health and Care ResearchWellcome TrustRoyal Devon and Exeter NHS Foundation TrustMedical Research CouncilCelltrionAbbVieCelltrion HealthcarePfizer
KeywordsMedicineAdalimumabInfliximabInternal medicineImmunologyTumor necrosis factor alphaCrohn's diseaseDiseaseOncology

Abstract

fetched live from OpenAlex

BACKGROUND AND AIMS: Anti-tumour necrosis factor [anti-TNF] therapy is widely used for the treatment of inflammatory bowel disease, yet many patients are primary non-responders, failing to respond to induction therapy. We aimed to identify blood gene expression differences between primary responders and primary non-responders to anti-TNF monoclonal antibodies [infliximab and adalimumab], and to predict response status from blood gene expression and clinical data. METHODS: The Personalised Anti-TNF Therapy in Crohn's Disease [PANTS] study is a UK-wide prospective observational cohort study of anti-TNF therapy outcome in anti-TNF-naive Crohn's disease patients [ClinicalTrials.gov identifier: NCT03088449]. Blood gene expression in 324 unique patients was measured by RNA-sequencing at baseline [week 0], and at weeks 14, 30, and 54 after treatment initiation [total sample size = 814]. RESULTS: After adjusting for clinical covariates and estimated blood cell composition, baseline expression of major histocompatibility complex, antigen presentation, myeloid cell enriched receptor, and other innate immune gene modules was significantly higher in anti-TNF responders vs non-responders. Expression changes from baseline to week 14 were generally of consistent direction but greater magnitude [i.e. amplified] in responders, but interferon-related genes were upregulated uniquely in non-responders. Expression differences between responders and non-responders observed at week 14 were maintained at weeks 30 and 54. Prediction of response status from baseline clinical data, cell composition, and module expression was poor. CONCLUSIONS: Baseline gene module expression was associated with primary response to anti-TNF therapy in PANTS patients. However, these baseline expression differences did not predict response with sufficient sensitivity for clinical use.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.226
Teacher spread0.220 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicInflammatory Bowel DiseaseFrench-language works237,207